Cargando…
The Role of Shared Decision-Making in Personalised Medicine: Opening the Debate
Surgeons and cancer patients are starting to open the debate on how personalised medicine could use shared decision-making (SDM) to balance the personal and clinical components and thus improve the quality and value of care. Personalised precision medicine (PPM) has traditionally focused on the use...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880233/ https://www.ncbi.nlm.nih.gov/pubmed/35215327 http://dx.doi.org/10.3390/ph15020215 |
_version_ | 1784659136412123136 |
---|---|
author | Guadalajara, Hector Lopez-Fernandez, Olatz León Arellano, Miguel Domínguez-Prieto, Víctor Caramés, Cristina Garcia-Olmo, Damian |
author_facet | Guadalajara, Hector Lopez-Fernandez, Olatz León Arellano, Miguel Domínguez-Prieto, Víctor Caramés, Cristina Garcia-Olmo, Damian |
author_sort | Guadalajara, Hector |
collection | PubMed |
description | Surgeons and cancer patients are starting to open the debate on how personalised medicine could use shared decision-making (SDM) to balance the personal and clinical components and thus improve the quality and value of care. Personalised precision medicine (PPM) has traditionally focused on the use of genomic information when prescribing treatments, which are usually pharmaceutical. However, the knowledge base is considerably scarcer in terms of how clinicians can individualise the information they provide patients about the consequences of different treatments, and in doing so involve them in the decision-making process. To achieve this, the ethical implications of SDM must be addressed from both sides. This paper explores the medical characteristics, the SDM implications in severe and fragile patients, potential risks, and observed benefits within this healthcare approach through four clinical cases. Findings shed light on current needs for clinician and patient training and tools related to SDM in PPM, and also remarks on the way in which this shift in healthcare settings is taking place to include the human component together with the biological and technological advances when designing care processes in colorectal cancer. |
format | Online Article Text |
id | pubmed-8880233 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88802332022-02-26 The Role of Shared Decision-Making in Personalised Medicine: Opening the Debate Guadalajara, Hector Lopez-Fernandez, Olatz León Arellano, Miguel Domínguez-Prieto, Víctor Caramés, Cristina Garcia-Olmo, Damian Pharmaceuticals (Basel) Case Report Surgeons and cancer patients are starting to open the debate on how personalised medicine could use shared decision-making (SDM) to balance the personal and clinical components and thus improve the quality and value of care. Personalised precision medicine (PPM) has traditionally focused on the use of genomic information when prescribing treatments, which are usually pharmaceutical. However, the knowledge base is considerably scarcer in terms of how clinicians can individualise the information they provide patients about the consequences of different treatments, and in doing so involve them in the decision-making process. To achieve this, the ethical implications of SDM must be addressed from both sides. This paper explores the medical characteristics, the SDM implications in severe and fragile patients, potential risks, and observed benefits within this healthcare approach through four clinical cases. Findings shed light on current needs for clinician and patient training and tools related to SDM in PPM, and also remarks on the way in which this shift in healthcare settings is taking place to include the human component together with the biological and technological advances when designing care processes in colorectal cancer. MDPI 2022-02-10 /pmc/articles/PMC8880233/ /pubmed/35215327 http://dx.doi.org/10.3390/ph15020215 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Case Report Guadalajara, Hector Lopez-Fernandez, Olatz León Arellano, Miguel Domínguez-Prieto, Víctor Caramés, Cristina Garcia-Olmo, Damian The Role of Shared Decision-Making in Personalised Medicine: Opening the Debate |
title | The Role of Shared Decision-Making in Personalised Medicine: Opening the Debate |
title_full | The Role of Shared Decision-Making in Personalised Medicine: Opening the Debate |
title_fullStr | The Role of Shared Decision-Making in Personalised Medicine: Opening the Debate |
title_full_unstemmed | The Role of Shared Decision-Making in Personalised Medicine: Opening the Debate |
title_short | The Role of Shared Decision-Making in Personalised Medicine: Opening the Debate |
title_sort | role of shared decision-making in personalised medicine: opening the debate |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880233/ https://www.ncbi.nlm.nih.gov/pubmed/35215327 http://dx.doi.org/10.3390/ph15020215 |
work_keys_str_mv | AT guadalajarahector theroleofshareddecisionmakinginpersonalisedmedicineopeningthedebate AT lopezfernandezolatz theroleofshareddecisionmakinginpersonalisedmedicineopeningthedebate AT leonarellanomiguel theroleofshareddecisionmakinginpersonalisedmedicineopeningthedebate AT dominguezprietovictor theroleofshareddecisionmakinginpersonalisedmedicineopeningthedebate AT caramescristina theroleofshareddecisionmakinginpersonalisedmedicineopeningthedebate AT garciaolmodamian theroleofshareddecisionmakinginpersonalisedmedicineopeningthedebate AT guadalajarahector roleofshareddecisionmakinginpersonalisedmedicineopeningthedebate AT lopezfernandezolatz roleofshareddecisionmakinginpersonalisedmedicineopeningthedebate AT leonarellanomiguel roleofshareddecisionmakinginpersonalisedmedicineopeningthedebate AT dominguezprietovictor roleofshareddecisionmakinginpersonalisedmedicineopeningthedebate AT caramescristina roleofshareddecisionmakinginpersonalisedmedicineopeningthedebate AT garciaolmodamian roleofshareddecisionmakinginpersonalisedmedicineopeningthedebate |